American Diabetes Association And Entelos, Inc. Announce In Silico Research Funding Opportunity

ALEXANDRIA, VA and FOSTER CITY, CA -- (MARKET WIRE) -- January 17, 2007 -- The American Diabetes Association (ADA) and Entelos, Inc. (LSE: ENTL) announced today a funding opportunity to support basic research through the Diabetes Research Center (DRC), a joint initiative of the ADA and Entelos to enhance the understanding of diabetes and its treatment. Awardees will have access to the DRC’s in silico modeling and biosimulation capabilities, allowing them an unparalleled ability to investigate the onset, progression, and treatment of diabetes.

MORE ON THIS TOPIC